Demonstration programs like this are designed to test new approaches to care and coverage, with the goal of improving outcomes and affordability for Medicare beneficiaries
Albiglutide (GlaxoSmithKline) is a fusion of two GLP-1 molecules with human albumin, which increases the proteolytic stability of GLP-1 and slows renal clearance, extending the half-life to 120 h
Anderberg et al
Animal model studies consistently demonstrated that semaglutide can significantly alter gut microbiota, suggesting that part of semaglutides metabolic benefit may derive from its capacity to modulate inflammation via gut-immune-microbiota interactions and to correct dysbiosis induced by high-fat diets [82, 84]
Retatrutide is still experimental
Key areas including the role of glucagon in the kidney, the effect of glucagon on the heart, and the question of the importance of GCGR signalling for brain-associated metabolism and function including appetite and food intake, remain unresolved